cultivate(MD)

cultivate(MD) operates as a venture capital fund dedicated to investing in medical device companies. The firm’s core approach involves providing strategic capital to medical technologies that promise to enhance patient outcomes and simultaneously drive down healthcare costs. Leveraging extensive experience across various healthcare disciplines, cultivate(MD) targets investments predominantly within the medical device and orthopedic technology sectors, fostering the development and market entry of innovative solutions.

The fund originated from Genesis Innovation Group, a leader in medical device development. Launched in 2017, cultivate(MD) was established with a pivotal insight stemming from Genesis Innovation Group’s founders, who collectively possess a significant portfolio of patents and innovations. R. Sean Churchill, MD, MBA, serves as the Managing Director, channeling his dual expertise as a physician and investor to guide investments in technologies designed to deliver tangible improvements in healthcare.

The fund's primary beneficiaries are emerging medical device companies seeking financial backing and strategic guidance to advance their innovations. cultivate(MD) envisions a future where cutting-edge medical technologies are efficiently brought to market, ultimately improving patient lives and optimizing healthcare expenditures. The firm remains committed to its mission of identifying and nurturing transformative solutions within the medical technology landscape.